Status
Conditions
Treatments
About
This study will evaluate relaxin (RLX) levels in patients with multiple sclerosis.
Full description
The goal of this study is to obtain baseline information on serum and cerebrospinal fluid (CSF) relaxin levels in patients with MS, as well as to further study RXFP-1 receptor binding affinity for RLX in patients with active and clinically stable MS.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
30 participants in 3 patient groups
Loading...
Central trial contact
Hannah Voss; Chiayi Chen, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal